Answers are grounded in this paper and cite their sources.
The widespread adoption of flow chemistry in research remains limited by the cost and availability of suitable reactor equipment. 3D-printed (3DP) reactors could bridge this gap, but their adoption is limited because the thermal and chemical resistance of the printing materials are not yet fully understood. In this study, we establish an experimentally validated material selection platform that enables the selection and use of low-cost heat- and chemically resistant 3DP flow reactors in a wide range of synthetic applications. Reactors fabricated from polypropylene (PP), polyamide 6 (PA6), polyvinylidene fluoride (PVDF), and their composites by fused filament fabrication (FFF) remained leak-free at elevated temperature (>100 °C) and pressure (up to 20 bar). Glass- and carbon-fiber-reinforced materials enabled reliable operation up to 160 °C and 20 bar. The utility of the 3DP reactors was demonstrated in transformations relevant to the pharmaceutical industry, including alkylations, sulfonylation, Suzuki coupling, organometallic reactions, and photochemical processes. The resulting yields, productivities, and space-time yields were comparable to those obtained in commercial flow systems. These results should promote the broader use of accessible 3DP reactors and provide general guidelines for their safe and effective application.
No takes yet. Share an insight, caveat, or question.
Orosz et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: